³í¹®) Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study ¿¬¼¼¾Ïº´¿ø Æó¾Ï¼¾ÅÍ Á¾¾ç³»°ú È«¹ÎÈñ(»çÁø ñ§)‧±èÇý·Ã ±³¼ö(ñé)¿Í ±¹¸³¾Ï¼¾ÅÍ ¾Èº´Ã¶ ±³¼ö(éÓ) ¿¬±¸ÆÀ